Lander: New cancer plan ‘more ambitious by far’ than original moonshot

WASHINGTON — A more modest cancer moonshot?

Not so fast, says Eric Lander. The White House science adviser pushed back on the many characterizations of the new effort as smaller and less ambitious than the 2016 push, in an interview with STAT this week.

Lander stressed that the current effort shouldn’t be viewed as an attempt to scale back the federal government’s cancer-curing ambitions. Even though it makes no mention of cancer “cures,” and doesn’t call for new research money, Lander argued the new plan is “audacious.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In